US Broker Ratings

Nuvation Bio Inc. (NUVB) Stock Analysis: A Biotech with 136% Upside Potential

Nuvation Bio Inc. (NASDAQ: NUVB) is drawing significant attention in the biotechnology sector, particularly for its innovative approaches in oncology. With a market capitalization of $1.09..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Navigating Challenges with 30% Revenue Growth

Investors looking at the healthcare sector might find Sonida Senior Living, Inc. (SNDA) to be a compelling yet complex investment opportunity. Specializing in senior housing communities..

CureVac N.V. (CVAC) Stock Analysis: Unlocking Growth Potential in mRNA Technology

CureVac N.V. (CVAC) is a notable player in the biotechnology sector, specializing in the innovative realm of messenger ribonucleic acid (mRNA) technology. Headquartered in Tübingen, Germany,..

Arcus Biosciences, Inc. (RCUS) Investor Outlook: Exploring a Potential 128% Upside in Biotech Innovation

Arcus Biosciences, Inc. (RCUS), a trailblazer in the biotechnology sector, is capturing the attention of investors with its promising cancer therapy pipeline and notable potential upside...

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Navigating a Challenging Market with a 36% Upside Potential

As individual investors scour the healthcare sector for promising opportunities, Cross Country Healthcare, Inc. (NASDAQ: CCRN) presents itself as a compelling yet complex prospect. Headquartered in..

Bioventus Inc. (BVS) Stock Analysis: Exploring a Potential 77% Upside for Investors

Bioventus Inc. (NASDAQ: BVS), a prominent player in the healthcare sector specializing in medical devices, is garnering attention from investors due to its promising growth potential..

Surmodics, Inc. (SRDX) Stock Analysis: Navigating the Healthcare Device Sector with Strategic Insight

Surmodics, Inc. (NASDAQ: SRDX) stands as a notable player within the healthcare sector, specifically in the medical devices industry. With a market capitalization of approximately $460.67..

InnovAge Holding Corp. (INNV) Stock Analysis: Navigating the Healthcare Sector with a Modest Upside

InnovAge Holding Corp. (NASDAQ: INNV) operates at the intersection of healthcare and community support, offering a comprehensive suite of services aimed at allowing seniors to live..

COMPASS Pathways Plc (CMPS): Analyst Ratings Indicate a 193% Potential Upside in the Healthcare Sector

COMPASS Pathways Plc (NASDAQ: CMPS) is a name that has been capturing attention within the healthcare sector, particularly among investors eyeing significant potential returns. Operating at..

Owens & Minor, Inc. (OMI) Stock Analysis: Navigating Challenges with a 10.21% Potential Upside

Owens & Minor, Inc. (NYSE: OMI) stands as a venerable entity in the healthcare sector, with a history dating back to 1882. This U.S.-based medical distribution..

Bicara Therapeutics Inc. (BCAX) Stock Analysis: A Promising Biotech with 184% Potential Upside

For investors with a keen eye on the biotechnology sector, Bicara Therapeutics Inc. (NASDAQ: BCAX) presents an intriguing opportunity. As a clinical-stage biopharmaceutical company focused on..

Orthofix Medical Inc. (OFIX) Stock Analysis: A 45% Potential Upside and Strong Buy Ratings

Orthofix Medical Inc. (NASDAQ: OFIX), a notable player in the healthcare sector specializing in medical devices, presents an intriguing opportunity for investors. With its current market..

Amylyx Pharmaceuticals (AMLX) Stock Analysis: Promising Potential with a 12% Upside Despite Financial Challenges

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) stands as a noteworthy player in the biotechnology sector, particularly for investors intrigued by companies engaged in cutting-edge neurodegenerative disease treatments...

LENZ Therapeutics, Inc. (LENZ): A Biotech Gem with 22% Upside Potential

LENZ Therapeutics, Inc. (NASDAQ: LENZ) has emerged as a promising player in the biotechnology sector, focusing its efforts on developing groundbreaking therapies to enhance vision. With..

Savara, Inc. (SVRA) Stock Analysis: Biotech with a Promising 171% Potential Upside

Savara, Inc. (NASDAQ: SVRA), a clinical-stage biopharmaceutical company, is capturing attention within the healthcare sector, specifically in the biotechnology industry. With a market capitalization of $622.21..

Sana Biotechnology, Inc. (SANA)

⚠️ No article content returned.

..

Syndax Pharmaceuticals (SNDX): Analyst Consensus Signals 142.72% Potential Upside

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX), a commercial-stage biopharmaceutical company, is gaining attention in the biotechnology sector, thanks to a robust analyst consensus that forecasts a potential..

AnaptysBio, Inc. (ANAB) Stock Analysis: Exploring a 135% Potential Upside in the Biotech Arena

AnaptysBio, Inc. (NASDAQ: ANAB) stands as a compelling player in the biotechnology sector, garnering attention from investors due to its promising pipeline of immunology therapeutics. The..

Cel-Sci Corporation (CVM) Stock Analysis: A Biotech with a 1,918% Potential Upside

Cel-Sci Corporation (NASDAQ: CVM), a clinical-stage biotechnology firm, is capturing investor attention with its staggering potential upside of 1,918.11%, based on an average target price of..

AMN Healthcare Services Inc (AMN) Stock Analysis: Understanding the Dynamics Behind Its 3.84% Potential Upside

Investors seeking opportunities in the healthcare sector may find AMN Healthcare Services Inc (AMN) an intriguing prospect. With its market cap standing at $738.13 million, AMN..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds